|Articles|April 1, 1999

A Multidisciplined Approach to Improving the Treatment of Allergic Rhinitis in the Managed Care Popu
Volume 5
Issue 4 Suppl

Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

Author(s)Richard Santos, PhD, Mary Cifaldi, RPh, MSHA, Cindy Gregory, PhD

Download PDF: Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

Articles in this issue

almost 27 years ago

Article

Participating Faculty

almost 27 years ago

Article

Selected Abstracts

almost 27 years ago

Article

Bibliography

almost 27 years ago

Article

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

almost 27 years ago

Article

Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis

almost 27 years ago

Article

Diagnosis and Treatment of Allergic Rhinitis: Primary Care in an Integrated Health System Setting

almost 27 years ago

Article

CME Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AI-Supported Mammography Caught More Cancers During Screening

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment